BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Antitrust: Commission Closes Procedural Case Against Servier


1/30/2012 7:59:15 AM

(NewDesignWorld Press Center) - Brussels - The Commission has closed an investigation into Les Laboratoires Servier for suspected provision of misleading and incorrect information to the Commission's pharmaceuticals sector inquiry.

In 2010, the Commission addressed statements of objections to Les Laboratoires Servier and Servier SAS, a French pharmaceutical company, taking the provisional view that Servier had provided misleading and incorrect information in reply to a request for information in the context of the pharmaceutical sector inquiry. In its reply to the statement of objections Servier put forward various arguments as to why the information it supplied was neither misleading nor incorrect. In light of Servier's arguments which would require significant further investigation, the Commission has decided to close the case, and instead focus on the substantive enforcement of competition rules in a number of pending cases, including one involving Servier.

In July 2009, the Commission opened a case against Servier and a number of other companies for suspected breaches of the rules on restrictive agreements (Article 101) and on abuse of a dominant market position (Article 102 see MEMO/09/322). This investigation is currently on-going.

In 2008-2009, the Commission carried out a broad competition inquiry into the pharmaceutical sector with a particular focus on practices to delay the market entry of generic medicines, which can cause significant consumer harm.




Servier
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->